Showing results (91-100 of 126) with videos related to
Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancerElisabeth I Heath, David W Hillman, Ulka Vaishampayan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancerSteven Attia, Jens Eickhoff, George Wilding, et al.Clinical Genitourinary Cancer|June 22, 2019
Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate CancerAlison R Roth, Stephanie A Harmon, Timothy G Perk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancerDouglas G McNeel, Edward J Dunphy, James G Davies, et al.The Prostate|January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With EnzalutamideChristos E Kyriakopoulos, Elisabeth I Heath, Anna Ferrari, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 23, 2016
Repeatability of Quantitative 18F-NaF PET: A Multicenter StudyChristie Lin, Tyler Bradshaw, Timothy Perk, et al.Investigational New Drugs|August 8, 2018
Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)Paul Monk, Glenn Liu, Walter M Stadler, et al.British Journal of Cancer|February 22, 2017
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trialRoberto Pili, Glenn Liu, Sreenivasulu Chintala, et al.American Heart Journal|February 7, 2012
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitorsRichard M Steingart, George L Bakris, Helen X Chen, et al.Pageof 13